Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting tumour metabolism.

Literature DB >> 20592733

Targeting tumour metabolism.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2010 PMID： 20592733 DOI： 10.1038/nrd3215

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

× No keyword cloud information.

3 in total

1. Pyruvate kinase M2 is a phosphotyrosine-binding protein.

Authors: Heather R Christofk; Matthew G Vander Heiden; Ning Wu; John M Asara; Lewis C Cantley
Journal: Nature Date: 2008-03-13 Impact factor: 49.962

2. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors: Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal: Nature Date: 2009-02-12 Impact factor: 49.962

3. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors: Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal: Nature Date: 2009-12-10 Impact factor: 49.962

3 in total

7 in total

1. Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins.

Authors: Kimberly Romero Rosales; Gurpreet Singh; Kevin Wu; Jie Chen; Matthew R Janes; Michael B Lilly; Eigen R Peralta; Leah J Siskind; Michael J Bennett; David A Fruman; Aimee L Edinger
Journal: Biochem J Date: 2011-10-15 Impact factor: 3.857

Review 2. Targeting tumour-supportive cellular machineries in anticancer drug development.

Authors: Matthias Dobbelstein; Ute Moll
Journal: Nat Rev Drug Discov Date: 2014-03 Impact factor: 84.694

3. Synthesis, characterization, and biological studies of emissive rhenium-glutamine conjugates.

Authors: Rachel Huang; Graeme Langille; Ravanjir K Gill; Cindy Mei Jin Li; Yuji Mikata; May Q Wong; Donald T Yapp; Tim Storr
Journal: J Biol Inorg Chem Date: 2013-08-08 Impact factor: 3.358

4. Microfluidic model with air-walls reveals fibroblasts and keratinocytes modulate melanoma cell phenotype, migration, and metabolism.

Authors: Jose M Ayuso; Shreyans Sadangi; Marcos Lares; Shujah Rehman; Mouhita Humayun; Kathryn M Denecke; Melissa C Skala; David J Beebe; Vijayasaradhi Setaluri
Journal: Lab Chip Date: 2021-02-03 Impact factor: 6.799